Vimarsana
Biggest News Aggregation in the World

Micro Photon Devices News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Micro Photon Devices. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Micro Photon Devices Today - Breaking & Trending Today

What is Quantum Microscopy? - Vimarsana News

What is Quantum Microscopy?

Particle manipulation has always been crucial to enhancing scattering and microscopy methods for material studies. In light of this strategy, researchers integrated quantum technology and microscopy to study the particles and molecules at the atomic level, which is unattainable using a conventional microscope.

Quantum Light Transmitted Through Phase-Separated Anderson Localization Fiber | Research & Technology | Dec 2022 - Vimarsana News

Quantum Light Transmitted Through Phase-Separated Anderson Localization Fiber | Research & Technology | Dec 2022

Following its development by a team at Corning in 1970, low-loss optical fiber became the best means to efficiently transport information from one pla

Heriot-Watt team improves robustness of quantum communications... - Vimarsana News

Heriot-Watt team improves robustness of quantum communications...

...and ICFO group transports two-photon quantum states over specially-adapted optical fiber.

Source: optics.org
Achieving A Quantum Fiber - Vimarsana News

Achieving A Quantum Fiber

Researchers from ICFO, Corning Incorporated, Micro Photon Devices, and Politecnico di Milano successfully demonstrate the transport of two-photon...

Politecnico di Milano: EU-funded tomographic imaging system moves to clinical validation phase - Vimarsana News

Politecnico di Milano: EU-funded tomographic imaging system moves to clinical validation phase

The SOLUS Project, coordinated by the Politecnico di Milano, has come to a close with the creation of an innovative multimodal tomographic imaging system for improving breast cancer diagnosis. The system, developed to discriminate noninvasively between malignant and benign lesions, is currently in the clinical validation phase at the San Raffaele Hospital. The validation will last two years, but initial results will be already available in the next months.